Skip to main content
TipRanks
Go Ultimate75% OFF

Pure Biologics SA (PQB) Ratios

0 Followers

Pure Biologics SA Ratios

DE:PQB's free cash flow for Q1 2026 was zł-3.17M. For the 2026 fiscal year, DE:PQB's free cash flow was increased by zł0.00 and operating cash flow was zł-3.17M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio0.250.142.701.887.75
Quick Ratio0.250.142.701.887.75
Cash Ratio0.000.020.450.181.11
Solvency Ratio-0.51-1.25-1.43-1.62-1.32
Operating Cash Flow Ratio-0.33-0.70-2.91-1.35-4.33
Short-Term Operating Cash Flow Coverage-0.40-0.780.000.000.00
Net Current Asset Valuezł -14.27Mzł -13.35Mzł 755.00Kzł 9.46Mzł 35.31M
Leverage Ratios
Debt-to-Assets Ratio3.246.000.570.090.07
Debt-to-Equity Ratio-1.13-1.076.830.160.08
Debt-to-Capital Ratio8.6114.910.870.140.07
Long-Term Debt-to-Capital Ratio0.000.000.870.000.00
Financial Leverage Ratio-0.35-0.1812.011.801.20
Debt Service Coverage Ratio-0.34-0.80-6.80-71.57-43.72
Interest Coverage Ratio-2.88-9.31-8.27-74.86-46.18
Debt to Market Cap0.910.160.320.000.00
Interest Debt Per Share3.703.005.261.441.50
Net Debt to EBITDA-2.59-1.12-0.36-0.030.36
Profitability Margins
Gross Profit Margin0.00%0.00%-2709.47%-816.77%-1585.43%
EBIT Margin0.00%0.00%-33537.89%-3817.82%-4542.52%
EBITDA Margin0.00%0.00%-27449.47%-3440.63%-3392.91%
Operating Profit Margin0.00%0.00%-33387.37%-3720.39%-4126.77%
Pretax Profit Margin0.00%0.00%-37572.63%-3867.52%-4631.89%
Net Profit Margin0.00%0.00%-37572.63%-3983.69%-5146.06%
Continuous Operations Profit Margin0.00%0.00%-37572.63%-3867.52%-4631.89%
Net Income Per EBT125.34%147.36%100.00%103.00%111.10%
EBT Per EBIT123.76%106.51%112.54%103.95%112.24%
Return on Assets (ROA)-198.79%-829.49%-156.98%-79.89%-27.70%
Return on Equity (ROE)69.41%148.18%-1885.58%-144.13%-33.10%
Return on Capital Employed (ROCE)45.17%94.41%-215.11%-122.08%-25.17%
Return on Invested Capital (ROIC)-336.04%-1311.76%-213.86%-115.79%-24.52%
Return on Tangible Assets-198.79%-873.09%-158.77%-80.87%-28.12%
Earnings Yield-56.03%-22.00%-88.54%-51.62%-7.56%
Efficiency Ratios
Receivables Turnover0.000.000.010.040.03
Payables Turnover0.060.052.600.846.35
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.000.000.110.080.07
Asset Turnover0.000.000.000.020.01
Working Capital Turnover Ratio0.000.000.010.030.02
Cash Conversion Cycle-5823.93-6752.5056511.397954.3613292.34
Days of Sales Outstanding0.000.0056651.848389.4913349.80
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding5823.936752.50140.45435.1357.47
Operating Cycle0.000.0056651.848389.4913349.80
Cash Flow Ratios
Operating Cash Flow Per Share-1.28-2.11-7.29-7.83-10.82
Free Cash Flow Per Share-1.28-2.11-7.35-10.42-11.12
Dividend Paid and CapEx Coverage Ratio0.000.00-132.17-3.02-35.71
Capital Expenditure Coverage Ratio0.000.00-132.17-3.02-35.71
Operating Cash Flow Coverage Ratio-0.39-0.77-1.80-6.08-7.72
Operating Cash Flow to Sales Ratio0.000.00-244.86-26.26-94.63
Free Cash Flow Yield-35.82%-12.26%-58.14%-45.31%-14.30%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-1.79-4.55-1.13-1.94-13.22
Price-to-Sales (P/S) Ratio0.000.00424.3777.17680.33
Price-to-Book (P/B) Ratio-1.24-6.7321.302.794.38
Price-to-Free Cash Flow (P/FCF) Ratio-2.79-8.16-1.72-2.21-6.99
Price-to-Operating Cash Flow Ratio-2.79-8.16-1.73-2.94-7.19
Price-to-Earnings Growth (PEG) Ratio0.040.070.20-0.020.67
Enterprise Value Multiple-5.43-8.34-1.90-2.27-19.70
Enterprise Value33.52M102.08M49.65M51.69M169.74M
EV to EBITDA-5.43-8.34-1.90-2.27-19.70
EV to Sales0.000.00522.6078.08668.26
EV to Free Cash Flow-5.34-9.43-2.12-2.23-6.87
EV to Operating Cash Flow-5.34-9.43-2.13-2.97-7.06
Tangible Book Value Per Share-2.87-2.580.518.0617.46
Shareholders’ Equity Per Share-2.87-2.550.598.2417.78
Tax and Other Ratios
Effective Tax Rate0.000.000.00-0.03-0.11
Revenue Per Share0.000.000.030.300.11
Net Income Per Share-1.99-3.78-11.19-11.87-5.88
Tax Burden1.251.471.001.031.11
Interest Burden1.241.071.121.011.02
Research & Development to Revenue0.000.000.0035.9381.02
SG&A to Revenue0.000.0068.8312.1314.95
Stock-Based Compensation to Revenue0.000.0013.716.6710.97
Income Quality0.800.560.650.682.04

Currency in PLN